Difficulty: Medium
Average Score: 95%
Practice
A male patient is receiving androgen therapy for hypogonadism. What adverse effect should the nurse monitor for during this therapy?
Correct answer
B
Rationale
In the context of pharmacology, understanding the potential adverse effects of medications is crucial for safe and effective patient care. In this scenario, the correct answer is B) Increased risk of cardiovascular events when a male patient is receiving androgen therapy for hypogonadism. Androgens, such as testosterone, can have various effects on the cardiovascular system, including increasing the risk of hypertension, dyslipidemia, and promoting atherosclerosis, which can lead to cardiovascular events like heart attacks and strokes.
Option A) Increased risk of bone fractures is incorrect because androgen therapy is actually associated with improved bone mineral density and can reduce the risk of osteoporosis.
Option C) Increased risk of liver dysfunction is not directly related to androgen therapy for hypogonadism. Liver dysfunction is more commonly associated with certain medications metabolized by the liver or conditions affecting liver function.
Option D) Increased risk of prostate cancer is a common concern with androgen therapy, but it is usually seen in patients with existing prostate cancer or predisposing factors. Regular monitoring of prostate-specific antigen (PSA) levels is important in patients receiving androgen therapy to detect any potential prostate issues early.
Educationally, this question highlights the importance of understanding the mechanism of action and potential side effects of medications, as well as the need for close monitoring and assessment of patients receiving pharmacological therapies to ensure optimal outcomes and patient safety in clinical practice.
Option A) Increased risk of bone fractures is incorrect because androgen therapy is actually associated with improved bone mineral density and can reduce the risk of osteoporosis.
Option C) Increased risk of liver dysfunction is not directly related to androgen therapy for hypogonadism. Liver dysfunction is more commonly associated with certain medications metabolized by the liver or conditions affecting liver function.
Option D) Increased risk of prostate cancer is a common concern with androgen therapy, but it is usually seen in patients with existing prostate cancer or predisposing factors. Regular monitoring of prostate-specific antigen (PSA) levels is important in patients receiving androgen therapy to detect any potential prostate issues early.
Educationally, this question highlights the importance of understanding the mechanism of action and potential side effects of medications, as well as the need for close monitoring and assessment of patients receiving pharmacological therapies to ensure optimal outcomes and patient safety in clinical practice.